Literature DB >> 3373426

Effect of excipients on tablet properties and dissolution behavior of theophylline-tableted microcapsules under different compression forces.

S Y Lin1.   

Abstract

Theophylline ethylcellulose microcapsules were tableted by compression with or without excipients [lactose or hydroxypropyl cellulose (HPC-H)]. Tablets without excipients had a crushing strength that was independent of the applied compression force and the particle size of the microcapsules used, but tablet thickness decreased with an increase in the particle size of the microcapsules. The dissolution characteristics of theophylline from tableted microcapsules without excipients were almost independent of the applied compression force, but showed a sustained-release behavior. However, the thickness, crushing strength, and dissolution properties of tablets containing excipients were found to be affected by the type of excipient. Tableted microcapsules containing lactose showed an increase in tablet crushing strength that correlated with an increase in the applied compression pressure, but the tablet thickness did not change. In contrast, tableted microcapsules containing HPC-H showed a decrease in tablet thickness with an increase in the applied compression pressure, but the tablet crushing strength was initially reduced and then increased with an increase in the compression force. There was a rapid release rate for theophylline from tableted microcapsules containing lactose; a zero-order release rate for theophylline was found in tableted microcapsules containing HPC-H. The insoluble compacted matrix formation, disintegration of tablet, rupture of microcapsules, and gel matrix formation may be responsible for the release behavior of theophylline-tableted microcapsules with or without excipients. The reduced surface area and porosity resulted in a prolongation of the release from tableted microcapsules compared with untableted microcapsules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373426     DOI: 10.1002/jps.2600770309

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Characterization and optimization of orodispersible mosapride film formulations.

Authors:  Aliaa N ElMeshad; Arwa S El Hagrasy
Journal:  AAPS PharmSciTech       Date:  2011-10-19       Impact factor: 3.246

2.  Formulation and evaluation of once daily minocycline hydrochloride extended release matrix tablets.

Authors:  R V Keny; S A Mankame; C F Lourenco
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

3.  Formulation and evaluation of rizatriptan benzoate mouth disintegrating tablets.

Authors:  R V Keny; Chrisma Desouza; C F Lourenco
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

4.  A novel approach to the oral delivery of micro- or nanoparticles.

Authors:  R Bodmeier; H G Chen; O Paeratakul
Journal:  Pharm Res       Date:  1989-05       Impact factor: 4.200

5.  Preparation and evaluation of sodium diclofenac controlled-release tablets. II. Dibasic calcium phosphate as a retardant in mixtures for direct compression.

Authors:  S Y Lin; C L Cheng; P C Lin
Journal:  Pharm World Sci       Date:  1995-03-24

6.  Design optimization and in vitro-in vivo evaluation of orally dissolving strips of clobazam.

Authors:  Rajni Bala; Sushil Khanna; Pravin Pawar
Journal:  J Drug Deliv       Date:  2014-09-28

7.  The Impact of Amorphisation and Spheronization Techniques on the Improved in Vitro & in Vivo Performance of Glimepiride Tablets.

Authors:  Rana Refaat Makar; Randa Latif; Ehab Ahmed Hosni; Omaima Naim El Gazayerly
Journal:  Adv Pharm Bull       Date:  2017-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.